Skip to content
Catalyst

lactoferrinFinding

Lactoferrin decreases late-onset sepsis incidence (neonatal)

lowersVery limited evidenceFindingreplicated ×2

01 · The sentence it was drawn from

“Meta-analysis of data from twelve randomized controlled trials showed that lactoferrin supplementation to enteral feeds decreased late-onset sepsis (typical RR 0.82, 95% CI 0.74 to 0.91; typical RD -0.04, 95% CI, -0.06, -0.02; NNTB 25, 95% CI 17 to 50; 12 studies, 5425 participants, low-certainty evidence) and decreased length of hospital stay (MD -2.38, 95% CI, -4.67, -0.09; 3 studies, 1079 participants, low-certainty evidence).”
Quoted verbatim from Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
This finding among the 3 findings on its endpoint

lactoferrin

Late-onset sepsis incidence (neonatal)

lowers

Effect as reported

0.82risk ratio

CI 0.74 to 0.91

Who
n = 5,425 · preterm neonates in randomised and quasi-randomised trials of lactoferrin added to enteral feeds (12 trials pooled)
Dose studied
not reported

Very limited evidencePMID 32232984 · 2020

02 · The study

Study
meta-analysis
Participants
5,425
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7PF1ZSB2KHCP8WK947WCHVV